據伊通社（IRNA）：伊朗少將伊茲迪表示，敵人不敢靠近伊朗海上邊界。

Phrontline Biopharma, a China-based antibody‑drug conjugate (ADC) developer, said it closed a Series A round of nearly $40m, bringing total new investment to about $100m over the past year. The round was led by Yuanhe Origin and Decheng Capital, with participation from Longpan Investment, Jifeng Capital, Mifang Health Fund, Songqing Capital and Jianfa Emerging Investment; Dianshi Capital served as exclusive financial adviser. Proceeds will accelerate clinical development of the core pipeline, support IND filings for differentiated reserve candidates, build a new payload platform and expand international collaborations and capitalization efforts.

現貨白銀回落至51美元/盎司下方，爲11月4日以來首次，日內跌1.43%。紐約期銀日內走低2.00%，現報50.96美元/盎司。